MiNK Therapeutics (6Q40.F) Q2 2025 Earnings

May 15Confirmed
Q4 2024
Q1 2025
Q2 2025
-0.76
-0.66
-0.55
-0.44

Details

Expected EPS
-0.543028566
Actual EPS
-0.625506
Surprise EPS
-0.08
Surprise Percent
-15.19%

Description

⁨MiNK Therapeutics⁩ (⁦6Q40.F⁩) has reported earnings of ⁦-0.625506⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts